Want to join the conversation?
$MAR expects its 4Q15 comparable system-wide RevPAR guidance for North America to be at the lower end of the previously guidance range of 5-7%, due to early fourth quarter transient RevPAR trends. Combined with continued unit growth, $MAR anticipates 4Q15 fee revenue should increase between 7-9%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?